Inflammation and gut permeability

Journal of HIV Therapy

Volumn 14, Issue 3, 2009, Pages 57-60

  Byakwaga, Helen ^a   Boesecke, Christoph ^a   Emery, Sean ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MICRORNA; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL TRANSLOCATION; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DENDRITIC CELL; DESMOSOME; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; ENTEROPATHY; ENZYME RECONSTITUTION; EPITHELIUM CELL; GASTROINTESTINAL TRACT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTESTINE MUCOSA; MALABSORPTION; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; TH17 CELL; UPREGULATION;

ANIMALS; EPITHELIAL CELLS; GASTROINTESTINAL TRACT; HIV; HIV INFECTIONS; HUMANS; INFLAMMATION; MACACA MULATTA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 74549116013     PISSN: 14620308     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Popovic M, Sarngadharan MG, Read E et al. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science, 1984, 224, 497-500.
2. Kotler DP, Gaetz HP, Lange M et al. Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med, 1984, 101, 421-428.
3. Batman PA,Miller AR, Forster SMet al. Jejunal enteropathy associated with human immunodeficiency virus infection: quantitative histology. J Clin Pathol, 1989, 42, 275-281.
4. Cummins AG, Labrooy JT, Stanley DP et al. Quantitative histological study of enteropathy associated with HIV infection. Gut, 1990, 31, 317-321.
5. Heise C, Miller CJ, Lackner A, Dandekar S. Primary acute simian immunodeficiency virus infection of intestinal lymphoid tissue is associated with gastrointestinal dysfunction. J Infect Dis, 1994, 169, 1116-1120.
6. Heise C, Vogel P, Miller CJ et al. Simian immunodeficiency virus infection of the gastrointestinal tract of rhesus macaques. Functional, pathological, and morphological changes. Am J Pathol, 1993, 142, 1759-1771.
7. Li Q, Estes JD, Duan L et al. Simian immunodeficiency virus induced intestinal cell apoptosis is the underlying mechanism of the regenerative enteropathy of early infection. J Infect Dis, 2008, 197, 420-429.
8. Sharpstone D, Neild P, Crane R et al. Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea. Gut, 1999, 45, 70-76.
9. Ullrich R, Zeitz M, Heise W et al. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Ann Intern Med, 1989, 111, 15-21.
10. Traber PG. Epithelial cell growth and differentiation. V. Transcriptional regulation, development, and neoplasia of the intestinal epithelium. Am J Physiol, 1997, 273, 979-981.
11. Liang SC, Tan XY, Luxenberg DP et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med, 2006, 203, 2271-2279.
12. MacDonald TT, Spencer J. Cell-mediated immune injury in the intestine. Gastroenterol Clin N Am, 1992, 21, 367-386.
13. Bjarnason I, Sharpstone DR, Francis N et al. Intestinal inflammation, ileal structure and function in HIV. AIDS, 1996, 10, 1385-1391.
14. Batman PA, Kotler DP, Kapembwa MS et al. HIV enteropathy: crypt stem and transit cell hyperproliferation induces villous atrophy in IV/microsporidia- infected jejunal mucosa. AIDS, 2007, 21, 433-439.
15. Ferreira RC, Forsyth LE, Richman PI et al. Changes in the rate of crypt epithelial cell proliferation and mucosal morphology induced by a T-cell-mediated response in human small intestine. Gastroenterology, 1990, 98, 1255-1263.
16. Griffiths CE, Barrison IG, Leonard JN et al. Preferential activation of CD4 T lymphocytes in the lamina propria of gluten-sensitive enteropathy. Clin Exp Immunol, 1988, 72, 280-283.
17. Mattapallil JJ, Douek DC, Hill B et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature, 2005, 434, 1093-1097.
18. Schieferdecker HL, Ullrich R, Hirseland H, Zeitz M. T cell differentiation antigens on lymphocytes in the human intestinal lamina propria. J Immunol, 1992, 149, 2816-2822.
19. Brenchley JM, Schacker TW, Ruff LE et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med, 2004, 200, 749-759.
20. Mehandru S, PolesMA, Tenner-Racz K et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med, 2004, 200, 761-770.
21. Guadalupe M, Reay E, Sankaran S et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol, 2003, 77, 11708-11717.
22. Arthos J, Cicala C, Martinelli E et al. HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol, 2008, 9, 301-309.
23. Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat Med, 2007, 13, 139-145.
24. Kao C-Y, Chen Y, Thai P et al. IL-17 markedly up-regulates {beta}- defensin-2 expression in human airway epithelium via JAK and NF- {kappa}B signaling pathways. J Immunol, 2004, 173, 3482-3491.
25. Brenchley JM, Paiardini M, Knox KS et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood, 2008, 112, 2826-2835.
26. Cecchinato V, Trindade CJ, Laurence A et al. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol, 2008, 1, 279-288.
27. Shanahan F. Intestinal lymphoepithelial communication. Adv Exp Med Biol, 1999, 473, 1-9.
28. Sankaran S, George MD, Reay E et al. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol, 2008, 82, 538-545.
29. Sankaran S, Guadalupe M, Reay E et al. Gut mucosal T cell responses and gene expression correlate with protection against disease in longterm HIV-1-infected nonprogressors. Proc Natl Acad Sci USA, 2005, 102, 9860-9865.
30. McGowan I, Elliott J, Fuerst M et al. Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation. J Acquir Immune Defic Syndr, 2004, 37, 1228-1236.
31. Olsson J, Poles M, Spetz AL et al. Human immunodeficiency virus type 1 infection is associated with significant mucosal inflammation characterized by increased expression of CCR5, CXCR4, and betachemokines. J Infect Dis, 2000, 182, 1625-1635.
32. Reka S, Garro ML, Kotler DP. Variation in the expression of human immunodeficiency virus RNA and cytokine mRNA in rectal mucosa during the progression of infection. Lymphokine Cytokine Res, 1994, 13, 391-398.
33. Abel K, Rocke DM, Chohan B et al. Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection. J Virol, 2005, 79, 12164-12172.
34. Turner JR. Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am J Pathol, 2006, 169, 1901-1909.
35. Lackner AA, Mohan M, Veazey RS et al. The gastrointestinal tract and AIDS pathogenesis. Gastroenterology, 2009, 136, 1965-1978.
36. Burdett IDJ. Aspects of the structure and assembly of desmosomes. Micron, 1998, 29, 309-328.
37. Tsukita S, FuruseM, ItohM. Structural and signalling molecules come together at tight junctions. Curr Opin Cell Biol, 1999, 11, 628-633.
38. Yap AS, Brieher WM, Gumbiner BM. Molecular and functional analysis of cadherin-based adherens junctions. Annu Rev Cell Dev Biol, 1997, 13, 119-146.
39. Blair SA, Kane SV, Clayburgh DR et al. Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab Invest, 2006, 86, 191-201.
40. Shen L, Black ED, Witkowski ED et al. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci, 2006, 119, 2095-2106.
41. Ambros V. The functions of animal microRNAs. Nature, 2004, 431, 350-355.
42. Griffiths-Jones S, Grocock RJ, van Dongen S et al. miRBase: microRNA sequences, targets and gene nomenclature. Nucl Acids Res, 2006, 34, D140-144.
43. Tang Y, Banan A, Forsyth CB et al. Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol Clin Exp Res, 2008, 32, 355-364.
44. Ancuta P, Kamat A, Kunstman KJ et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One, 2008, 3, e2516.
45. Balagopal A, Philp FH, Astemborski J et al. Human immunodeficiency irus-related microbial translocation and progression of hepatitis C. astroenterology, 2008, 135, 226-233.
46. Brenchley JM, Price DA, Schacker TWet al. Microbial translocation is cause of systemic immune activation in chronic HIV infection. Nat ed, 2006, 12, 1365-1371.
47. Mohan M, Aye PP, Borda JT et al. Gastrointestinal disease in simian immunodeficiency virus-infected rhesus macaques is characterized by proinflammatory dysregulation of the interleukin-6-Janus kinase/signal transducer and activator of transcription3 pathway. Am J Pathol, 2007, 171, 1952-1965.
48. Atreya R, Neurath MF. Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer. Curr Drug Targets, 2008, 9, 369-374.
49. de Beaucoudrey L, Puel A, Filipe-Santos O et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med, 2008, 205, 1543-1550.
50. Mohan M, Aye PP, Borda JT et al. CCAAT/enhancer binding protein beta is a major mediator of inflammation and viral replication in the gastrointestinal tract of simian immunodeficiency virus-infected rhesus macaques. Am J Pathol, 2008, 173, 106-118.
51. Gordon SN, Klatt NR, Bosinger SE et al. Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys. J Immunol, 2007, 179, 3026-3034.
52. Pandrea I, Gaufin T, Brenchley JM et al. Cutting edge: experimentally induced immune activation in natural hosts of simian immunodeficiency virus induces significant increases in viral replication and CD4+ T cell depletion. J Immunol, 2008, 181, 6687-6691.
53. Silvestri G, Sodora DL, Koup et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity, 2003, 18, 441-452.
54. Smith C, Sabin C, Lampe F. The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy. AIDS, 2003, 17, 963-969.
55. Mehandru S, PolesMA, Tenner-Racz K et al. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. PLoS Med, 2006, 3, e484.
56. Poles MA, BoscardinWJ, Elliott J et al. Lack of decay of HIV-1 in gutassociated lymphoid tissue reservoirs in maximally suppressed individuals. J Acquir Immune Defic Syndr, 2006, 43, 65-68.
57. George MD, Reay E, Sankaran S et al. Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration. J Virol, 2005, 79, 2709-2719.
58. Guadalupe M, Sankaran S, George MD et al. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J Virol, 2006, 80, 8236-8247.
59. Estes J, Baker JV, Brenchley JM et al. Collagen deposition limits immune reconstitution in the gut. J Infect Dis, 2008, 198, 456-464.
60. Tincati C, Biasin M, Bandera A et al. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection. Antivir Ther, 2009, 14, 321-330.
61. Epple HJ, Schneider T, Troeger H et al. Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIVinfected patients. Gut, 2009, 58, 220-227.
62. Giorgi JV, Hultin LE, McKeating et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis, 1999, 179, 859-870.
63. Hazenberg MD, Otto SA, van Benthem BH et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS, 2003, 17, 1881-1888.